WebApr 6, 2024 · Objective This study sought to explore the burden experienced by informal caregivers in caring for their children with sickle cell disease (SCD). Design A qualitative exploratory design was employed in the study using in-depth interviews. Setting The study was conducted at the sickle cell clinic of the Tamale Teaching Hospital, Ghana. … WebMar 14, 2024 · Background: Sickle cell disease (SCD) is a genetic red blood cell disorder associated with severe complications including chronic anemia, stroke, and vaso-occlusive crises (VOCs). VOCs are unpredictable, difficult to treat, and the leading cause of hospitalization. Recent efforts have focused on the use of mobile health technology to …
NIH scientists discover how DNA fragments can trigger inflammation in …
WebDec 4, 2024 · Chronic pain in sickle cell disease (SCD) refers to pain that is present on most days and has lasted at least 6 months. 1 It can start as early as childhood, and its prevalence increases with age. By adulthood, more than 55% of patients experience pain on more than half of days, with nearly one third (29%) reporting pain on 95% of days. 2 The true … WebBackground: Previous natural history studies have advanced the understanding of sickle cell disease (SCD), but generally have not included sufficient lifespan data or investigation of the role of genetics in clinical outcomes, and have often occurred before the widespread use of disease-modifying therapies, such as hydroxyurea and chronic erythrocyte transfusions. cushman and wakefield people search
Examining Sickle Cell Disease Research at Duke School of Nursing
WebApr 11, 2024 · As part of the ongoing trial, the researchers examined the incidence of precipitated withdrawal among people who received buprenorphine. Results were published on March 30, 2024, in JAMA Network Open. Overall, only 9 out of the 1,200 people—or less than 1%—in the study experienced precipitated withdrawal after starting buprenorphine. WebThe Hibiscus Study™ is recruiting males and females 12 to 65 years of age to take part in a clinical research study of an investigational medication for treatment of sickle cell disease. See if you may qualify. We are currently enrolling people 12 to 65 years of age who have a confirmed diagnosis of sickle cell disease (SCD). If you are ... WebJun 25, 2024 · Modeling revealed that in patients with sickle cell anemia, the acute chest syndrome, renal failure, seizures, a base-line white-cell count above 15,000 cells per cubic millimeter, and a low level ... chase sapphire priority pass sign up